Download video

Anti-HER2 Mechanisms of Approved HER2 Inhibitors

156K views

HMP Education

11 years ago

Anti-HER2 Mechanisms of Approved HER2 Inhibitors

Anti-HER2 Mechanisms of Approved HER2 Inhibitors

Anti-HER2 Mechanisms of Approved HER2 Inhibitors
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
by HMP Education
Dr. Hurvitz on FDA Approval of Subcutaneous Trastuzumab Formulation in HER2+ Breast Cancer
1:00
Dr. Hurvitz on FDA Approval of Subcutaneous Trastuzumab Formulation in HER2+ Breast Cancer
by OncLive
Anti HER2 Mechanisms of Approved HER2 Inhibitors
5:05
Anti HER2 Mechanisms of Approved HER2 Inhibitors
by khanh nguyen van
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
0:57
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
by OncLive
【HER2 inhibitors】Trastuzumab(Herceptin®), Pertuzumab, Lapatinib, Antibody-drug conjugates (KADCYLA®)
5:40
【HER2 inhibitors】Trastuzumab(Herceptin®), Pertuzumab, Lapatinib, Antibody-drug conjugates (KADCYLA®)
by StudyMed
Two Dimensions in Targeting HER2
1:50
Two Dimensions in Targeting HER2
by ASCOcancer
HER2 Targeted Therapies
2:50
HER2 Targeted Therapies
by Susan G. Komen®
Dr. Bhave on Promising Anti-HER2 Agents in HER2+ Breast Cancer
1:37
Dr. Bhave on Promising Anti-HER2 Agents in HER2+ Breast Cancer
by OncLive
Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets
31:21
Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets
by HMP Education
Spotlight Poster Discussion: \\
16:06
Spotlight Poster Discussion: \\"HER2 kinase inhibitors: neoadjuvant approaches and mechanisms of...\\"
by San Antonio Breast Cancer Symposium
Dr. Cristina Saura Anti Her2 therapy
14:20
Dr. Cristina Saura Anti Her2 therapy
by OncoAlert 360
HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors
51:24
HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors
by PeerView Oncology
Neratinib for Metastatic Breast Cancer
3:15
Neratinib for Metastatic Breast Cancer
by OncLive
ER+\/HER2+ Metastatic Breast Cancer
3:19
ER+\/HER2+ Metastatic Breast Cancer
by OncLive
HER2-E pCR with anti-HER2-based neoadjuvant therapies
2:49
HER2-E pCR with anti-HER2-based neoadjuvant therapies
by VJOncology
Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms
30:57
Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms
by Total Health | Oncology
Margetuximab for the treatment of HER2-positive breast cancer
2:43
Margetuximab for the treatment of HER2-positive breast cancer
by ecancer
DESTINY-Gastric03: trastuzumab deruxtecan in HER2-overexpressing gastric cancer
4:41
DESTINY-Gastric03: trastuzumab deruxtecan in HER2-overexpressing gastric cancer
by VJOncology
Neratinib in HER2+ Breast Cancer
9:35
Neratinib in HER2+ Breast Cancer
by OncLive